Literature DB >> 12022343

Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis.

Solveig Wållberg-Jonsson1, Jasmina Trifunovic Cvetkovic, Karl-Gösta Sundqvist, Ann Kari Lefvert, Solbritt Rantapää-Dahlqvist.   

Abstract

OBJECTIVE: To measure markers of atherogenesis and thrombogenesis in patients with rheumatoid arthritis (RA) and in matched controls, and to relate these variables to markers of inflammation and endothelial activation, and to the presence of atherosclerosis.
METHODS: Thirty-nine patients with RA with disease onset between 1974 and 1978, who were younger than 65 years at the present study in 1997, were investigated together with 39 age and sex matched controls. IgG, IgA, and IgM antibodies against oxidized low density lipoprotein (oxLDL ab), malondialdehyde LDL (MDA-LDL ab) and cardiolipin (aCL) were measured by ELISA, circulating immune complexes (CIC) were isolated by precipitation, and homocysteine was measured with HPLC. Hemostatic factors of endothelial origin, i.e., plasminogen activator inhibitor-1 (PAI-1 mass), von Willebrand Factor (vWF), and D-dimer were analyzed by ELISA, and tissue plasminogen activator (tPA) activity was analyzed by a chromogen method. The products analyzed in the RA group correlated with soluble adhesion molecules (sICAM-1, sE-selectin), acute phase reactants, interleukin 6 (IL-6), and IL-2sR alpha, all measured by ELISA, and with accumulated disease activity. The factors were also related to the presence of plaque measured by duplex scanning. Factor analysis was performed to subgroup data in order to find latent variables.
RESULTS: Patients with RA had significantly higher levels of oxLDL ab (IgM), MDA-LDL ab (IgA, IgM classes), aCL (IgG, IgA, IgM classes), CIC, homocysteine, PAI-1 mass, and D-dimer than controls. Patients also had significantly higher levels of sICAM-1, sE-selectin, IL-6, and IL-2sR alpha. PAI-1 mass, D-dimer, vWF, CIC, and aCL (IgM, IgA) correlated with erythrocyte sedimentation rate (ESR), and, with the exception of vWF, to accumulated disease activity. CIC correlated significantly with IgM antibodies against oxLDL and aCL. ESR, IL-2sR alpha, PAI-1, tPA activity, vWF, D-dimer, homocysteine, aCL (IgA), and MDA-LDL ab (IgA) correlated with sICAM-1. ESR, haptoglobin, IL-2sR alpha, PAI-1 mass, D-dimer, aCL (IgM), and MDA-LDL ab (IgM) correlated with sE-selectin. sICAM-1 was significantly higher in patients with plaque. In factor analysis, presence of atherosclerotic plaque had loadings of one latent variable together with adhesion molecules and IL-2sR alpha and together with antibodies of, in particular, IgM type of another one.
CONCLUSION: Several different etiopathogenic mechanisms for increased cardiovascular mortality in RA are implicated. Continuous endothelial activation is suggested by increased levels of adhesion molecules sICAM-1 and sE-selectin, which correlate with hemostatic factors of endothelial origin and with T cell activation as measured by IL2sR alpha. That factor analysis showed loadings of one variable on antilipid antibodies and plaque and another on T cell activation and plaque indicates that the immune system is involved in the development of atherosclerosis in RA.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12022343

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  39 in total

1.  Common carotid intima-media thickness and von Willebrand factor serum levels in rheumatoid arthritis female patients without cardiovascular risk factors.

Authors:  Leonel Daza; Martin Aguirre; Martin Jimenez; Rafael Herrera; J J Bollain
Journal:  Clin Rheumatol       Date:  2006-06-07       Impact factor: 2.980

Review 2.  [Systemic manifestations of rheumatoid arthritis].

Authors:  M Uffmann
Journal:  Radiologe       Date:  2006-05       Impact factor: 0.635

3.  Association of hyperhomocysteinemia with genetic variants in key enzymes of homocysteine metabolism and methotrexate toxicity in rheumatoid arthritis patients.

Authors:  Souhir Chaabane; Meriam Messedi; Rim Akrout; Mariem Ben Hamad; Mouna Turki; Sameh Marzouk; Leila Keskes; Zouheir Bahloul; Ahmed Rebai; Fatma Ayedi; Abdellatif Maalej
Journal:  Inflamm Res       Date:  2018-05-23       Impact factor: 4.575

4.  An atypical case of typical chest pain.

Authors:  Francesco Casella; Ilaria Bossi; Giuseppina Pisano; Nicola Montano
Journal:  Intern Emerg Med       Date:  2008-04-17       Impact factor: 3.397

5.  Tc-99m sestamibi lower extremity muscle scan, is it a useful screening tool for assessment of preclinical atherosclerosis in rheumatoid arthritis patients?

Authors:  Amr M Amin; Zeinab O Nawito; Rania A Atfy; Khaled T El-Hadidi
Journal:  Rheumatol Int       Date:  2011-04-13       Impact factor: 2.631

Review 6.  Vasculitis associated with connective tissue disorders.

Authors:  Mittie K Doyle
Journal:  Curr Rheumatol Rep       Date:  2006-08       Impact factor: 4.592

Review 7.  Dysfunctional HDL in diabetes mellitus and its role in the pathogenesis of cardiovascular disease.

Authors:  Rai Ajit K Srivastava
Journal:  Mol Cell Biochem       Date:  2017-08-21       Impact factor: 3.396

8.  Folate/homocysteine phenotypes and MTHFR 677C>T genotypes are associated with serum levels of monocyte chemoattractant protein-1.

Authors:  Andrea L Hammons; Carolyn M Summers; Jayne V Woodside; Helene McNulty; J J Strain; Ian S Young; Liam Murray; Colin A Boreham; John M Scott; Laura E Mitchell; Alexander S Whitehead
Journal:  Clin Immunol       Date:  2009-07-21       Impact factor: 3.969

9.  Derangement of hemostasis in rheumatoid arthritis: association with demographic, inflammatory and metabolic factors.

Authors:  Theodoros Dimitroulas; Karen M J Douglas; Vasileios F Panoulas; Tracey Toms; Jacqueline P Smith; Gareth J Treharne; Peter Nightingale; James Hodson; George D Kitas
Journal:  Clin Rheumatol       Date:  2013-05-15       Impact factor: 2.980

Review 10.  The consequences of HIV infection and antiretroviral therapy use for cardiovascular disease risk: shifting paradigms.

Authors:  Jason V Baker; W Keith Henry; James D Neaton
Journal:  Curr Opin HIV AIDS       Date:  2009-05       Impact factor: 4.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.